HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic

Go back to HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic
(NASDAQ: HCWB) Delayed: 1.08 -0.08 (6.9%)
Previous Close $1.16    52 Week High
Open $1.10    52 Week Low
Day High $1.15    P/E N/A 
Day Low $1.08    EPS
Volume 291,054